Cargando…

Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF

BACKGROUND: The association of recombinant FSH plus recombinant LH in 2:1 ratio may be used not only to induce ovulation in anovulatory women with hypogonadotropic hypogonadism but also to achieve multiple follicular developments in human IVF. The aim of this analysis was to estimate the cost-effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mennini, F. S., Marcellusi, A., Viti, R., Bini, C., Carosso, A., Revelli, A., Benedetto, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052706/ https://www.ncbi.nlm.nih.gov/pubmed/30021630 http://dx.doi.org/10.1186/s12958-018-0386-2

Ejemplares similares

Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population
por: Revelli, Alberto, et al.
Publicado: (2015)

Effect of rLH Supplementation during Controlled Ovarian Stimulation for IVF: Evidence from a Retrospective Analysis of 1470 Poor/Suboptimal/Normal Responders Receiving Either rFSH plus rLH or rFSH Alone
por: Canosa, Stefano, et al.
Publicado: (2022)

Correlation of the Day 3 FSH/LH Ratio and LH Concentration in Predicting IVF Outcome
por: Prasad, Sudha, et al.
Publicado: (2013)

Recombinant follicular stimulating hormone plus recombinant luteinizing hormone versus human menopausal gonadotropins- does the source of LH bioactivity affect ovarian stimulation outcome?
por: Kirshenbaum, M., et al.
Publicado: (2021)

Comparison between cycles of the same patients when using recombinant luteinizing hormone + recombinant follicle stimulating hormone (rFSH), human menopausal gonadotropin + rFSH and rFSH only
por: Tayyar, Ahter Tanay, et al.
Publicado: (2018)

Human Menopausal Gonadotropin versus Recombinant FSH in Polycystic Ovary Syndrome Patients Undergoing In Vitro Fertilization
por: Figen Turkcapar, Ayse, et al.
Publicado: (2013)

Controlled ovarian stimulation with r-FSH plus r-LH vs. HMG plus r-FSH in patients candidate for IVF/ICSI cycles: An RCT
por: Shahrokh Tehraninejad, Ensieh, et al.
Publicado: (2017)

Human Recombinant FSH and Its Biosimilars: Clinical Efficacy, Safety, and Cost-Effectiveness in Controlled Ovarian Stimulation for In Vitro Fertilization
por: Bergandi, Loredana, et al.
Publicado: (2020)

Establishment of specific enzyme-linked immunosorbent assay (ELISA) for measuring Fsh and Lh levels in medaka (Oryzias latipes), using recombinant gonadotropins
por: Burow, Susann, et al.
Publicado: (2019)

Letter to Editor on “Correlation of the Day 3 FSH/LH Ratio and LH Concentration in Predicting IVF Outcome”
por: Morgante, Giuseppe
Publicado: (2014)

Differential gene expression in human granulosa cells from recombinant FSH versus human menopausal gonadotropin ovarian stimulation protocols
por: Brannian, John, et al.
Publicado: (2010)

Differential Regulation of Gonadotropins as Revealed by Transcriptomes of Distinct LH and FSH Cells of Fish Pituitary
por: Hollander-Cohen, Lian, et al.
Publicado: (2021)

Associations of LH and FSH with reproductive hormones depending on each stage of the menopausal transition
por: Kawakita, Takako, et al.
Publicado: (2023)

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
por: Carosso, Andrea Roberto, et al.
Publicado: (2021)

Effects of recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-agonist protocol: a matched case-control study
por: Franco, José G, et al.
Publicado: (2009)

Comparison of recombinant human follicle stimulating hormone (rhFSH), human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG) on semen parameters after varicocelectomy: a randomized clinical trial
por: Amirzargar, Mohammad Ali, et al.
Publicado: (2012)

Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation
por: Levi Setti, P. E., et al.
Publicado: (2014)

The Role of Urinary LH and FSH in the Diagnosis of Pubertal Disorders
por: Tripathy, Manoranjan, et al.
Publicado: (2021)

Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2017)

Reduced FSH and LH action: implications for medically assisted reproduction
por: Bosch, E, et al.
Publicado: (2021)

Body Mass Index and Gonadotropin Hormones (LH & FSH) Associate With Clinical Symptoms Among Women With Polycystic Ovary Syndrome
por: Esmaeilzadeh, Seddigheh, et al.
Publicado: (2015)

Recombinant Fsh and Lh therapy for spawning induction of previtellogenic and early spermatogenic arrested teleost, the flathead grey mullet (Mugil cephalus)
por: Ramos-Júdez, Sandra, et al.
Publicado: (2022)

Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Younis, Johnny S.
Publicado: (2017)

Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis
por: Marcellusi, Andrea, et al.
Publicado: (2018)

Response: Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2018)

Weak evidence of bright light effects on human LH and FSH
por: Kripke, Daniel F, et al.
Publicado: (2010)

Effects of Extra-Long-Acting Recombinant Bovine FSH (bscrFSH) on Cattle Superovulation
por: Gutiérrez-Reinoso, Miguel A., et al.
Publicado: (2022)

Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis
por: Revelli, Alberto, et al.
Publicado: (2006)

Effects of human chorionic gonadotropin combined with clomiphene on Serum E(2), FSH, LH and PRL levels in patients with polycystic ovarian syndrome
por: Yonggang, Huang, et al.
Publicado: (2017)

Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF
por: Biasoni, Valentina, et al.
Publicado: (2011)

Oestrogen-selective modulation of FSH and LH secretion by pituitary gland
por: Mitwally, M F, et al.
Publicado: (2005)

Regulation of progesterone during follicular development by FSH and LH in sheep
por: Ding, Ziqiang, et al.
Publicado: (2022)

Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis
por: Lehert, Philippe, et al.
Publicado: (2014)

Age-dependent changes in anti-Müllerian hormone levels in Lebanese females: correlation with basal FSH and LH levels and LH/FSH ratio: a cross-sectional study
por: Racoubian, Eddie, et al.
Publicado: (2020)

FSH in vitro versus LH in vivo: similar genomic effects on the cumulus
por: Assidi, Mourad, et al.
Publicado: (2013)

Serum LH/FSH ratios in 87 infants with differences of sex development
por: Ljubicic, Marie Lindhardt, et al.
Publicado: (2023)

The Ala307Thr polymorphism of the follicle-stimulating hormone receptor (FSHR) gene is associated with the dose of recombinant FSH received during IVF/ICSI treatment
por: Dieamant, Felipe, et al.
Publicado: (2023)

Women in Advanced Reproductive Age: Are the Follicular Output Rate, the Follicle-Oocyte Index and the Ovarian Sensitivity Index Predictors of Live Birth in an IVF Cycle?
por: Carosso, Andrea Roberto, et al.
Publicado: (2022)

Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis
por: Khair, Andrew, et al.
Publicado: (2023)

Data on Western blot and ELISA analysis of medaka (Oryzias latipes) follicle-stimulating hormone (Fsh) and luteinizing hormone (Lh) using recombinant proteins expressed with Pichia pastoris
por: Burow, Susann, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bhaokg9kkqf8f2tul8f2h97kfa